Fabry disease: Diagnosis and treatment

Slides:

Advertisements

Similar presentations

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Advertisements

Volume 62, Issue 6, Pages (December 2002)

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Renal manifestations in Fabry disease and therapeutic options

Anemia management in chronic kidney disease

Volume 56, Pages S95-S98 (November 1999)

Approach to diagnosis of infective endocarditis

Parapelvic cysts leading to a diagnosis of Fabry disease

Shining light on vitamin D trials in chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Non-amyloid fibrils in heavy chain deposition disease

Volume 70, Pages S21-S25 (December 2006)

George A. Kaysen, Burl R. Don

Comorbidity and confounding in end-stage renal disease

A new era in phosphate binder therapy: What are the options?

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Kamila Czene, Ph.D., Kari Hemminki Kidney International

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

The epidemiology of chronic kidney disease

Renal vascular sclerosis is associated with inherited thrombophilias

Thomas Quaschning, Jan Galle, Christoph Wanner

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 59, Issue 4, Pages (April 2001)

Endothelial dysfunction and inflammation: What is the link?

New insights in uremic toxins

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Nephrology in Latin America, with special emphasis on Brazil

AGEs in foods: Do they play a role in uremia?

Volume 93, Issue 1, Pages (January 2018)

Fabry disease: An underrecognized cause of proteinuria

Nitric oxide, oxidative stress, and apoptosis

Simvastatin in nephrotic syndrome

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 56, Pages S235-S237 (July 1999)

Volume 71, Issue 4, Pages (February 2007)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 74, Issue 11, Pages (December 2008)

Volume 88, Issue 6, Pages (December 2015)

Daily nocturnal home hemodialysis

Peritoneal dialysis in Mexico

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia Markus Ketteler, Christoph.

Volume 56, Pages S71-S74 (November 1999)

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

Quiz page answers August 2003

Quiz Page June 2009 American Journal of Kidney Diseases

Charles A. Herzog Kidney International

Volume 71, Issue 9, Pages (May 2007)

The Case ∣ An Asian boy with proteinuria

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

The international realities of live donor kidney transplantation

The International Pediatric Peritonitis Registry: Starting to walk

Renal vascular disease in the elderly

Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Volume 55, Pages S41-S46 (June 1999)

Morphology of the heart and arteries in renal failure

Development and differentiation of endothelium

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Alex B. Magil, Kathryn Tinckam Kidney International

Tissue proteomics: a new investigative tool for renal biopsy analysis

Presentation transcript:

Fabry disease: Diagnosis and treatment Frank Breunig, Frank Weidemann, Meinrad Beer, Andreas Eggert, Vera Krane, Matthias Spindler, Jörn Sandstede, Jörg Strotmann, Christoph Wanner Kidney International Volume 63, Pages S181-S185 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.5.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Typical angiokeratomas in Fabry disease. Characteristic dark-red to blue-dark angiectases, typically found between the umbilicus and thigh. The lesions range in size from pinpoint to several millimeters. Kidney International 2003 63, S181-S185DOI: (10.1046/j.1523-1755.63.s84.5.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Electron micrograph showing the electron dense lipid depositions in the vascular endothelium (arrows) of a skin capillary from a 29-year-old male Fabry patient (magnification x 3000). Kidney International 2003 63, S181-S185DOI: (10.1046/j.1523-1755.63.s84.5.x) Copyright © 2003 International Society of Nephrology Terms and Conditions